All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know AML

The AML Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Has the role of haploidentical transplant changed in AML?

During the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the AML Hub spoke to Arnon Nagler, Tel Aviv University, Tel Aviv, IL. We asked, Has the role of haploidentical transplant changed in AML?

Has the role of haploidentical transplant changed in AML?

Haploidentical transplantation has revolutionized the field, as it offers the opportunity of a donor to almost every patient in need of transplant. In this video, Nagler discusses the benefits of haploidentical transplantation for patients with AML.

 

Share: